For localized information and support, would you like to switch to your country-specific website for {0}?
Clinically actionable respiratory testing across the continuum of care
Roche PCR respiratory solutions deliver timely, high-quality insights for confident decision-making in every setting and situation.
In the face of complex and ever-evolving respiratory challenges, you need diagnostic solutions that offer both precision and flexibility.
It’s now possible to offer polymerase chain reaction (PCR) - or lab quality respiratory testing - for patients in all settings. This can include urgent care clinics, doctor’s offices, emergency departments, hospital labs and more. And it’s possible to partner with just one manufacturer to ensure the availability of high-quality testing in each of those settings and for the unique situations and preferences of your providers and their patients.
Roche PCR respiratory solutions: Transforming what’s possible in respiratory testing
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Roche has developed a comprehensive range of respiratory tests, technologies and assays for primary, secondary, and community care settings. We are helping customers to transform what’s possible with respiratory testing.
Show video transcript
Quick, targeted point-of-care testing
cobas® liat system
- Provides results in 20 minutes or less supporting real-time clinical decision-making
- Intuitive, easy to use interface
- Frontline multiplex assays
Comprehensive and fast results
cobas® ePlex system .
- Urgent results for high-risk patients in ~1.5 hours
- Broad pathogen detection panels (viral and bacterial)
- Modular & scalable
- Easy-to-use workflow
Flexible and efficient testing
cobas® 5800/6800/8800 systems
- Flexible ordering/ reporting
- Scalable solutions for labs of all sizes
- Minimal and intuitive technician interactions
The Roche respiratory testing continuum
Outlining possibilities to enhance care across all pathways with Roche respiratory solutions
Introduction to cobas® Respiratory flex
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Featured products
IVD
For in vitro diagnostic use.
cobas® Respiratory flex, Qualitative nucleic acid test for use on the cobas® 5800/6800/8800 systems
cobas® Respiratory flex for use on the cobas® 5800/6800/8800 Systems (cobas® Respiratory flex) is an automated, multiplex, nucleic acid test that utilizes real-time polymerase chain reaction (PCR) technology for simultaneous in vitro qualitative detection and differentiation of adenovirus (species B, C and E), common human coronaviruses (229E, HKU1, NL63, OC43), human metapneumovirus, human rhinovirus/enterovirus, influenza A virus, influenza B virus, parainfluenza viruses 1, 2, 3, and 4, respiratory syncytial virus (RSV), and SARS-CoV-2 in nasopharyngeal swab specimens obtained from individuals with signs and symptoms of respiratory tract infections in conjunction with clinical and epidemiological risk factors.
The detection and identification of specific viral nucleic acids from individuals presenting with signs and symptoms of a respiratory infection aids in the diagnosis of respiratory infection if used in conjunction with other clinical and epidemiological information. Negative results do not preclude a respiratory infection and should not be used as the sole basis for treatment or other patient management decisions. Conversely, positive results do not rule out coinfection with other organisms, and the agent detected may not be the definite cause of disease.
Due to the genetic similarity between human rhinovirus and enterovirus, the cobas® Respiratory flex test cannot reliably differentiate them.
IVD
For in vitro diagnostic use.
cobas® Influenza A/B & RSV, Nucleic acid test for use on the cobas® liat system
Diagnose and differentiate influenza A/B & RSV for effective clinical management and infection control with the POC multiplex PCR test for use on the cobas® liat system.
